Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy

Thyroid

Volumn 18, Issue 11, 2008, Pages 1201-1206

  Yin, Xiaoming ^a   Latif, Rauf ^a   Bahn, Rebecca ^b   Tomer, Yaron ^c   Davies, Terry F ^a,d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

^d MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN RECEPTOR;

ADULT; ARTICLE; CAUCASIAN; CONTROLLED STUDY; CTLA 4 GENE; ENDOCRINE OPHTHALMOPATHY; FEMALE; GENE; GENE FREQUENCY; GENE LOCATION; GENETIC MARKER; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; INTRON; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; TSHR GENE;

ADULT; ALLELES; ANTIGENS, CD; BASE SEQUENCE; CASE-CONTROL STUDIES; DNA PRIMERS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GRAVES DISEASE; GRAVES OPHTHALMOPATHY; HASHIMOTO DISEASE; HUMANS; INTRONS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, THYROTROPIN; RISK FACTORS;

EID: 56549107801     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2008.0098     Document Type: Article

References (38)

1. Davies TF, Ando T, Lin RY, Tomer Y, Latif R 2005 Thyrotropin receptor-associated diseases: from adenomata to Graves disease. J Clin Invest 115:1972-1983.
2. de Roux N, Shields DC, Misrahi M, Ratanachaiyavong S, McGregor AM, Milgrom E 1996 Analysis of the thyrotropin receptor as a candidate gene in familial Graves' disease. J Clin Endocrinol Metab 81:3483-3486.
3. Sakai K, Shirasawa S, Ishikawa N, Ito K, Tamai H, Kuma K, Akamizu T, Tanimura M, Furugaki K, Yamamoto K, Sasazuki T 2001 Identification of susceptibility loci for autoimmune thyroid disease to 5q31-q33 and Hashimoto's thyroiditis to 8q23-q24 by multipoint affected sib-pair linkage analysis in Japanese. Hum Mol Genet 10:1379-1386.
4. Tomer Y, Barbesino G, Keddache M, Greenberg DA, Davies TF 1997 Mapping of a major susceptibility locus for Graves' disease (GD-1) to chromosome 14q31. J Clin Endocrinol Metab 82:1645-1648.
5. Allahabadia A, Heward JM, Mijovic C, Carr-Smith J, Daykin J, Cockram C, Barnett AH, Sheppard MC, Franklyn JA, Gough SC 1998 Lack of association between polymorphism of the thyrotropin receptor gene and Graves' disease in United Kingdom and Hong Kong Chinese patients: case control and family-based studies. Thyroid 8:777-780.
6. Kotsa KD, Watson PF, Weetman AP 1997 No association between a thyrotropin receptor gene polymorphism and Graves' disease in the female population. Thyroid 7:31-33.
7. Tomer Y, Ban Y, Concepcion E, Barbesino G, Villanueva R, Greenberg DA, Davies TF 2003 Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families. Am J Hum Genet 73:736-747.
8. Chistyakov DA, Savost'anov KV, Turakulov RI, Petunina NA, Trukhina LV, Kudinova AV, Balabolkin MI, Nosikov VV 2000 Complex association analysis of graves disease using a set of polymorphic markers. Mol Genet Metab 70:214-218.
9. Cuddihy RM, Dutton CM, Bahn RS 1995 A polymorphism in the extracellular domain of the thyrotropin receptor is highly associated with autoimmune thyroid disease in females. Thyroid 5:89-95.
10. Kaczur V, Takacs M, Szalai C, Falus A, Nagy Z, Berencsi G, Balazs C 2000 Analysis of the genetic variability of the 1st (CCC/ACC, P52T) and the 10th exons (bp 1012-1704) of the TSH receptor gene in Graves' disease. Eur J Immunogenet 27:17-23.
11. Simanainen J, Kinch A, Westermark K, Winsa B, Bengtsson M, Schuppert F, Westermark B, Heldin NE 1999 Analysis of mutations in exon 1 of the human thyrotropin receptor gene: high frequency of the D36H and P52T polymorphic variants. Thyroid 9:7-11.
12. Tonacchera M, Pinchera A 2000 Thyrotropin receptor polymorphisms and thyroid diseases. J Clin Endocrinol Metab 85:2637-2639.
13. Tomer Y, Barbesino G, Greenberg DA, Concepcion E, Davies TF 1999 Mapping the major susceptibility loci for familial Graves' and Hashimoto's diseases: evidence for genetic heterogeneity and gene interactions. J Clin Endocrinol Metab 84:4656-4664.
14. Mattick JS, Makunin IV 2006 Non-coding RNA. Hum Mol Genet 15 Spec No 1:R17-R29.
15. Nakaya HI, Amaral PP, Louro R, Lopes A, Fachel AA, Moreira YB, El-Jundi TA, da Silva AM, Reis EM, Verjovski-Almeida S 2007 Genome mapping and expression analyses of human intronic noncoding RNAs reveal tissue-specific patterns and enrichment in genes related to regulation of transcription. Genome Biol 8:R43.
16. Graves PN, Davies TF 2000 New insights into the thyroid-stimulating hormone receptor. The major antigen of Graves' disease. Endocrinol Metab Clin N Am 29:267-286, vi.
17. Ho SC, Goh SS, Khoo DH 2003 Association of Graves' disease with intragenic polymorphism of the thyrotropin receptor gene in a cohort of Singapore patients of multi-ethnic origins. Thyroid 13:523-528.
18. Hiratani H, Bowden DW, Ikegami S, Shirasawa S, Shimizu A, Iwatani Y, Akamizu T 2005 Multiple SNPs in intron 7 of thyrotropin receptor are associated with Graves' disease. J Clin Endocrinol Metab 90:2898-2903.
19. Dechairo BM, Zabaneh D, Collins J, Brand O, Dawson GJ, Green AP, MacKay I, Franklyn JA, Connell JM, Wass JA, Wiersinga WM, Hegedus L, Brix T, Robinson BG, Hunt PJ, Weetman AP, Carey AH, Gough SC 2005 Association of the TSHR gene with Graves' disease: the first disease specific locus. Eur J Hum Genet 13:1223-1230.
20. Tomer Y, Greenberg DA, Barbesino G, Concepcion E, Davies TF 2001 CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production. J Clin Endocrinol Metab 86:1687-1693.
21. Gauderman WJ 2002 Sample size requirements for association studies of gene-gene interaction. Am J Epidemiol 155:478-484.
22. Ban Y, Greenberg DA, Concepcion ES, Tomer Y 2002 A germline single nucleotide polymorphism at the intracellular domain of the human thyrotropin receptor does not have a major effect on the development of Graves' disease. Thyroid 12:1079-1083.
23. Ban Y, Davies TF, Greenberg DA, Kissin A, Marder B, Murphy B, Concepcion ES, Villanueva RB, Barbesino G, Ling V, Tomer Y 2003 Analysis of the CTLA-4, CD28, and inducible costimulator (ICOS) genes in autoimmune thyroid disease. Genes Immun 4:586-593.
24. Ban Y, Concepcion ES, Villanueva R, Greenberg DA, Davies TF, Tomer Y 2004 Analysis of immune regulatory genes in familial and sporadic Graves' disease. J Clin Endocrinol Metab 89:4562-4568.
25. Kavvoura FK, Akamizu T, Awata T, Ban Y, Chistiakov DA, Frydecka I, Ghaderi A, Gough SC, Hiromatsu Y, Ploski R, Wang PW, Ban Y, Bednarczuk T, Chistiakova EI, Chojm M, Heward JM, Hiratani H, Juo SH, Karabon L, Katayama S, Kurihara S, Liu RT, Miyake I, Omrani GH, Pawlak E, Taniyama M, Tozaki T, Ioannidis JP 2007 Cytotoxic Tlymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: a meta-analysis. J Clin Endocrinol Metab 92:3162-3170.
26. Huber AK, Jacobson EM, Jazdzewski K, Concepcion ES, Tomer Y 2008 Interleukin (IL)-23 receptor is a major susceptibility gene for Graves' ophthalmopathy: the IL-23/T-helper 17 axis extends to thyroid autoimmunity. J Clin Endocrinol Metab 93:1077-1081.
27. Jacobson EM, Tomer Y 2007 The genetic basis of thyroid autoimmunity. Thyroid 17:949-961.
28. Tomer Y, Davies TF 2003 Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr Rev 24:694-717.
29. Villanueva R, Inzerillo AM, Tomer Y, Barbesino G, Meltzer M, Concepcion ES, Greenberg DA, MacLaren N, Sun ZS, Zhang DM, Tucci S, Davies TF 2000 Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology. Thyroid 10:791-798.
30. Nagayama Y, Kaufman KD, Seto P, Rapoport B 1989 Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor. Biochem Biophys Res Commun 165:1184-1190.
31. Nagayama Y, Rapoport B 1992 The thyrotropin receptor 25 years after its discovery: new insight after its molecular cloning. Mol Endocrinol 6:145-156.
32. Gilbert W 1978 Why genes in pieces? Nature 271:501.
33. Amsellem S, Briffaut D, Carrie A, Rabes JP, Girardet JP, Fredenrich A, Moulin P, Krempf M, Reznik Y, Vialettes B, de Gennes JL, Brukert E, Benlian P 2002 Intronic mutations outside of Alu-repeat-rich domains of the LDL receptor gene are a cause of familial hypercholesterolemia. Hum Genet 111:501-510.
34. King K, Flinter FA, Nihalani V, Green PM 2002 Unusual deep intronic mutations in the COL4A5 gene cause X linked Alport syndrome. Hum Genet 111:548-554.
35. Xie X, Lu J, Kulbokas EJ, Golub TR, Mootha V, Lindblad-Toh K, Lander ES, Kellis M 2005 Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammals. Nature 434:338-345.
36. Kakinuma A, Nagayama Y 2002 Multiple messenger ribonucleic acid transcripts and revised gene organization of the human TSH receptor. Endocr J 49:175-180.
37. Graves PN, Tomer Y, Davies TF 1992 Cloning and sequencing of a 1.3 KB variant of human thyrotropin receptor mRNA lacking the transmembrane domain. Biochem Biophys Res Commun 187:1135-1143.
38. Thai TH, Calado DP, Casola S, Ansel KM, Xiao C, Xue Y, Murphy A, Frendewey D, Valenzuela D, Kutok JL, Schmidt-Supprian M, Rajewsky N, Yancopoulos G, Rao A, Rajewsky K 2007 Regulation of the germinal center response by microRNA-155. Science 316:604-608.